These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24607053)

  • 21. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
    Genovese MC; Becker JC; Schiff M; Luggen M; Sherrer Y; Kremer J; Birbara C; Box J; Natarajan K; Nuamah I; Li T; Aranda R; Hagerty DT; Dougados M
    N Engl J Med; 2005 Sep; 353(11):1114-23. PubMed ID: 16162882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5Rα antibody and TNFα inhibitor.
    Yamada H; Hida N; Kurashima Y; Satoh H; Saito T; Hizawa N
    Allergol Int; 2019 Oct; 68(4):536-538. PubMed ID: 31027977
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter: A case of generalized guttate psoriasis induced by etanercept with relapse after abatacept.
    Brigant F; Clavel G; Chatelain D; Lok C; Chaby G
    Dermatol Online J; 2011 Jun; 17(6):11. PubMed ID: 21696691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.
    Genovese MC; Schiff M; Luggen M; Becker JC; Aranda R; Teng J; Li T; Schmidely N; Le Bars M; Dougados M
    Ann Rheum Dis; 2008 Apr; 67(4):547-54. PubMed ID: 17921185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abatacept use in rheumatoid arthritis: evidence review and recommendations.
    Martín Mola E; Balsa A; Martínez Taboada V; Sanmartí R; Marenco JL; Navarro Sarabia F; Gómez-Reino J; Alvaro-Gracia JM; Román Ivorra JA; Lojo L; Plasencia C; Carmona L;
    Reumatol Clin; 2013; 9(1):5-17. PubMed ID: 22766432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fusion protein abatacept. Remission in every 5th TNF-alpha refractory patient].
    MMW Fortschr Med; 2008 Jun; 150(26-27):56-7. PubMed ID: 18683309
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.
    Weinblatt M; Schiff M; Goldman A; Kremer J; Luggen M; Li T; Chen D; Becker JC
    Ann Rheum Dis; 2007 Feb; 66(2):228-34. PubMed ID: 16935912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell agents in the treatment of rheumatoid arthritis.
    Solomon GE
    Bull NYU Hosp Jt Dis; 2010; 68(3):162-5. PubMed ID: 20969545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abatacept as add-on therapy for rheumatoid arthritis.
    Allison C
    Issues Emerg Health Technol; 2005 Sep; (73):1-4. PubMed ID: 16317826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alternatives in the treatment of rheumatoid arthritis: reasons for using abatacept].
    Castañeda S; Martínez Calatrava MJ; Herrero-Beaumont G
    Rev Clin Esp; 2012 May; 212(5):244-54. PubMed ID: 22176928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is abatacept an effective treatment for patients with RA who do not respond to other anti-TNF treatments?
    Taylor PC
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):128-9. PubMed ID: 16932670
    [No Abstract]   [Full Text] [Related]  

  • 32. QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy.
    Russell AS; Lisboa L; Santos MF; Kumar D; Humar A
    Clin Rheumatol; 2013 Nov; 32(11):1657-9. PubMed ID: 23754242
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.
    Emery P; Kosinski M; Li T; Martin M; Williams GR; Becker JC; Blaisdell B; Ware JE; Birbara C; Russell AS
    J Rheumatol; 2006 Apr; 33(4):681-9. PubMed ID: 16568505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy.
    Genovese MC; Schiff M; Luggen M; Le Bars M; Aranda R; Elegbe A; Dougados M
    J Rheumatol; 2012 Aug; 39(8):1546-54. PubMed ID: 22798265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom.
    Guyot P; Taylor PC; Christensen R; Pericleous L; Drost P; Eijgelshoven I; Bergman G; Lebmeier M
    J Rheumatol; 2012 Jun; 39(6):1198-206. PubMed ID: 22505698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orencia approved for rheumatoid arthritis.
    Health News; 2006 Mar; 12(3):2. PubMed ID: 16535763
    [No Abstract]   [Full Text] [Related]  

  • 37. Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment.
    Russell AS; Wallenstein GV; Li T; Martin MC; Maclean R; Blaisdell B; Gajria K; Cole JC; Becker JC; Emery P
    Ann Rheum Dis; 2007 Feb; 66(2):189-94. PubMed ID: 16984942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Productivity cost model of the treatment of rheumatoid arthritis with abatacept.
    Burton WN; Morrison A; Yuan Y; Li T; Marioni RE; Maclean R
    J Med Econ; 2008; 11(1):3-21. PubMed ID: 19450107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One more rheumatoid drug.
    Health News; 2004 Jan; 10(1):8. PubMed ID: 15002381
    [No Abstract]   [Full Text] [Related]  

  • 40. Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis.
    Amezcua-Guerra LM; Hernández-Martínez B; Pineda C; Bojalil R
    Gut; 2006 Jul; 55(7):1059-60. PubMed ID: 16766771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.